Skip to main content
Kindstar Globalgene Technology, Inc. logo

Kindstar Globalgene Technology, Inc. — Investor Relations & Filings

Ticker · 9960 ISIN · KYG5262E1044 HKEX Human health and social work activities
Open in API
Filings indexed 605 across all filing types
Latest filing 2022-04-25 Transaction in Own Shar…
Country HK Hong Kong
Listing HKEX 9960

About Kindstar Globalgene Technology, Inc.

http://www.kindstar.com.cn

Kindstar Globalgene Technology, Inc. is a leading independent provider of advanced specialty clinical testing services, specializing in esoteric testing. The company maintains the largest esoteric testing portfolio in its market, utilizing internationally-advanced laboratory facilities for clinical testing, scientific research, and applied R&D. Its comprehensive testing menu, featuring over 100 items, covers critical diagnostic areas including hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology. These services provide physicians and patients access to specialized diagnostics crucial for the diagnosis and treatment of major diseases.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Returns - Changes in issued share capital and/or share buyback
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details repurchases of shares, exercises of options, and confirmations related to compliance with listing rules on the Stock Exchange of Hong Kong. The content is focused on reporting share repurchases and capital changes, including detailed tables of shares repurchased and exercised, prices, and confirmations by company officers. This matches the description of a 'Transaction in Own Shares' filing, which reports the company's buyback or sale of its own shares. The document is not an announcement of a report, nor is it a full financial report or management discussion. Therefore, the appropriate classification is POS (Transaction in Own Shares). The document length and detail support a high confidence in this classification.
2022-04-25 English
Notification Letter and Request Form to Non-registered Shareholders
Report Publication Announcement Classification · 100% confidence The document is a notification letter addressed to non-registered shareholders informing them about the publication of the 2021 Annual Report, Circular, Notice of AGM, and Proxy Form on the company's website. It provides instructions on how shareholders can request printed copies of these corporate communications. The document does not contain the actual annual report or financial data but rather announces the availability of these reports and related materials. According to the 'MENU VS MEAL' rule, such a notification letter that states the report is published and available online, without including the report itself, should be classified as a Report Publication Announcement (RPA).
2022-04-25 English
PROXY FORM FOR THE ANNUAL GENERAL MEETING TO BE HELD ON WEDNESDAY, JUNE 1, 2022 (OR ANY ADJOURNMENT THEREOF)
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a proxy form for the Annual General Meeting (AGM) of Kindstar Globalgene Technology, Inc. It includes instructions for shareholders to appoint proxies to vote on various resolutions at the AGM, including adoption of audited financial statements, re-election of directors, appointment of auditors, and share repurchase and issuance mandates. The document is not the AGM presentation or minutes but the proxy solicitation form sent to shareholders to enable voting at the AGM. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI). The document length (7,831 characters) and content confirm it is not a brief announcement or a full report but a solicitation form for voting at the AGM.
2022-04-25 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information Classification · 100% confidence The document is a notice of the Annual General Meeting (AGM) for Kindstar Globalgene Technology, Inc. It includes details about the meeting date, agenda items such as receiving and adopting the audited consolidated financial statements for the year ended December 31, 2021, re-election of directors, appointment of auditors, and mandates for share repurchase and issuance. The document is clearly a formal notice inviting shareholders to the AGM and outlining the resolutions to be considered. It does not contain the actual financial statements or detailed reports but refers to the 2021 Annual Report being sent separately. The document length is about 12,516 characters, which is typical for an AGM notice but not a full report. Therefore, this document fits the category of AGM Information (AGM-R) as it is the meeting notice and materials shared for the AGM, not the full annual report or other filings.
2022-04-25 English
PROPOSED RE-ELECTION OF DIRECTORS AND PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES AND NOTICE OF ANNUAL GENERAL MEETING
AGM Information Classification · 100% confidence The document is a circular from Kindstar Globalgene Technology, Inc. regarding the proposed re-election of directors, granting of general mandates to repurchase and issue shares, and notice of the Annual General Meeting (AGM) scheduled for June 1, 2022. It includes detailed information about the AGM arrangements, proxy instructions, biographies of directors proposed for re-election, and explanatory statements related to share repurchase mandates. The document is clearly intended to inform shareholders about the AGM and related resolutions, which aligns with the definition of AGM Information (AGM-R). It is not a full annual report, financial statement, or earnings release, but rather materials shared in connection with the AGM. The length (15,000 characters) and content confirm it is a comprehensive circular for the AGM, not merely a brief announcement or proxy solicitation. Therefore, the appropriate classification is AGM Information (AGM-R).
2022-04-25 English
2021 Annual Report
Annual Report Classification · 100% confidence The document is titled '2021 Annual Report' and contains detailed sections typical of a full annual report, including business review, financial summary, chairman's statement, management discussion and analysis, directors and senior management, corporate governance report, environmental, social and governance report, directors' report, independent auditor's report, consolidated financial statements, and notes to the financial statements. The document length is 15,000 characters, indicating a comprehensive report rather than a brief announcement. The presence of audited financial statements and detailed corporate information confirms this is the official yearly report covering company activity and full financial performance for the fiscal year ended December 31, 2021. Therefore, the document fits the definition of an Annual Report (10-K). FY 2021
2022-04-25 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.